✦ LIBER ✦

Bosutinib induces high response rates in imatinib-resistant/intolerant CML patients

✍ Scribed by NEIL OSTERWEIL

Book ID: 118628305
Publisher: Frontline Medical Communications, Inc.
Year: 2010
Tongue: English
Weight: 59 KB
Volume: 7
Category: Article
ISSN: 1548-5315
DOI: 10.1016/s1548-5315(11)70585-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

NICE guidance on dasatinib, high-dose im

NICE guidance on dasatinib, high-dose imatinib, and nilotinib for patients with CML who are resistant or intolerant to imatinib

✍ Scott Goulden; Frances Sutcliffe; Andrew Stevens 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 47 KB

PCN13 Cost-Effectiveness Analysis of Nil

PCN13 Cost-Effectiveness Analysis of Nilotinib Versus Dasatinib in Patients With Imatinib-Resistant or Imatinib-Intolerant Chronic Myeloid Leukemia (CML)

✍ Niu, X.; Hay, J. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

PCN35 COST-EFFECTIVENESS ANALYSIS OF DAS

PCN35 COST-EFFECTIVENESS ANALYSIS OF DASATINIB FOR THE TREATMENT OF IMATINIB RESISTANT OR INTOLERANT CML PATIENTS IN BRAZIL

✍ C Ouissak; G Litalien; MR Alves 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

Health Related Quality of Life by Line o

✍ Whiteley, J.; Reisman, A.; Shapiro, M. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

A Phase I/II study of nilotinib in Japan

A Phase I/II study of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL

✍ Arinobu Tojo; Kensuke Usuki; Akio Urabe; Yasuhiro Maeda; Yukio Kobayashi; Itsuro 📂 Article 📅 2009 🏛 Carden Jennings Publishing 🌐 English ⚖ 184 KB

Dasatinib induces complete hematologic a

Dasatinib induces complete hematologic and cytogenetic responses in patients with imatinib-resistant or -intolerant chronic myeloid leukemia in blast crisis

✍ Cortes, J.; Rousselot, P.; Kim, D.-W.; Ritchie, E.; Hamerschlak, N.; Coutre, S.; 📂 Article 📅 2006 🏛 American Society of Hematology 🌐 English ⚖ 118 KB